These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 7475512

  • 1. Diuretic activity of N'-disubstituted morpholinoguanidine analogs of U-37883A in rats and dogs.
    Humphrey SJ, Ludens JH, Perricone SC, Skaletzky LL, Graham BE, Zins GR.
    Methods Find Exp Clin Pharmacol; 1995 May; 17(4):255-66. PubMed ID: 7475512
    [Abstract] [Full Text] [Related]

  • 2. Effects of K-ATP blocking guanidine diuretics during experimental kaliuresis in rats and dogs.
    Humphrey SJ.
    Methods Find Exp Clin Pharmacol; 1995 Oct; 17(8):519-28. PubMed ID: 8749224
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular effects of the K-ATP channel blocker U-37883A and structurally related morpholinoguanidines.
    Humphrey SJ, Smith MP, Cimini MG, Buchanan LV, Gibson JK, Khan SA, Meisheri KD.
    Methods Find Exp Clin Pharmacol; 1996 May; 18(4):247-60. PubMed ID: 8803957
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological Profile of U-37883A, a Channel Blocker of Smooth Muscle-Type ATP-Sensitive K Channels.
    Teramoto N.
    Cardiovasc Drug Rev; 2006 May; 24(1):25-32. PubMed ID: 16939631
    [Abstract] [Full Text] [Related]

  • 5. Guanidine derivative U-37883A, inhibits mitochondrial K+ uniport.
    Szewczyk A, Wójcik G, Jabłonowska A, Nałecz.
    Pol J Pharmacol; 1995 May; 47(4):339-44. PubMed ID: 8616514
    [Abstract] [Full Text] [Related]

  • 6. Interaction of the diuretics torasemide and U-37883A with the K(ATP) channel in rat isolated aorta.
    Löffler-Walz C, Quast U.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):230-7. PubMed ID: 9750009
    [Abstract] [Full Text] [Related]

  • 7. Effects of a K+ channel blocker on glomerular filtration rate and electrolyte excretion in conscious rats.
    Ludens JH, Clark MA, Lawson JA.
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1375-81. PubMed ID: 7791110
    [Abstract] [Full Text] [Related]

  • 8. K-ATP-blocking diuretic PNU-37883A reduces plasma renin activity in dogs.
    Humphrey SJ, Ludens JH.
    J Cardiovasc Pharmacol; 1998 Jun; 31(6):894-903. PubMed ID: 9641474
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and diuretic activity of alkyl- and arylguanidine analogs of N,N'-dicyclohexyl-4-morpholinecarboxamidine in rats and dogs.
    Perricone SC, Humphrey SJ, Skaletzky LL, Graham BE, Zandt RA, Zins GR.
    J Med Chem; 1994 Oct 28; 37(22):3693-700. PubMed ID: 7966129
    [Abstract] [Full Text] [Related]

  • 10. Functional receptors in Xenopus oocytes for U-37883A, a novel ATP-sensitive K+ channel blocker: comparison with rat insulinoma cells.
    Guillemare E, Honore E, De Weille J, Fosset M, Lazdunski M, Meisheri K.
    Mol Pharmacol; 1994 Jul 28; 46(1):139-45. PubMed ID: 8058048
    [Abstract] [Full Text] [Related]

  • 11. 4-morpholinecarboximidine-N-1-adamantyl-N'-cyclohexylhydrochloride (U-37883A): pharmacological characterization of a novel antagonist of vascular ATP-sensitive K+ channel openers.
    Meisheri KD, Humphrey SJ, Khan SA, Cipkus-Dubray LA, Smith MP, Jones AW.
    J Pharmacol Exp Ther; 1993 Aug 28; 266(2):655-65. PubMed ID: 8355199
    [Abstract] [Full Text] [Related]

  • 12. Multiple actions of U-37883A, an ATP-sensitive K+ channel blocker, on membrane currents in pig urethra.
    Tomoda T, Yunoki T, Naito S, Ito Y, Teramoto N.
    Eur J Pharmacol; 2005 Nov 07; 524(1-3):1-10. PubMed ID: 16242124
    [Abstract] [Full Text] [Related]

  • 13. Receptor binding characterization in kidney membrane of [3H]U-37883, a novel ATP-sensitive K+ channel blocker with diuretic/natriuretic properties.
    Meisheri K, Fosset M, Humphrey S, Lazdunski M.
    Mol Pharmacol; 1995 Jan 07; 47(1):155-63. PubMed ID: 7838124
    [Abstract] [Full Text] [Related]

  • 14. Effects of U-37883A on intracellular Ca2+ -activated large-conductance K+ channels in pig proximal urethral myocytes.
    Teramoto N, Aishima M, Zhu HL, Tomoda T, Yunoki T, Takahashi-Yanaga F, Brading AF, Ito Y.
    Eur J Pharmacol; 2004 Dec 03; 506(1):1-7. PubMed ID: 15588618
    [Abstract] [Full Text] [Related]

  • 15. The natriuretic activity of the K+ channel blocker U-37883A displays an ADH-dependence.
    Clark MA, Lawson JA, Ludens JH.
    Methods Find Exp Clin Pharmacol; 1998 Mar 03; 20(2):115-23. PubMed ID: 9604853
    [Abstract] [Full Text] [Related]

  • 16. Effects of a novel KATP channel blocker on renal tubule function and K channel activity.
    Wang T, Wang WH, Klein-Robbenhaar G, Giebisch G.
    J Pharmacol Exp Ther; 1995 Jun 03; 273(3):1382-9. PubMed ID: 7791111
    [Abstract] [Full Text] [Related]

  • 17. Negative modulation of nitric oxide production by neurotensin as a putative mechanism of the diuretic action of SR 48692 in rats.
    Croci T, Landi M, Gully D, Maffrand JP, Le Fur G, Manara L.
    Br J Pharmacol; 1997 Apr 03; 120(7):1312-8. PubMed ID: 9105707
    [Abstract] [Full Text] [Related]

  • 18. Natriuretic effect of [7-glycine]oxytocin in the presence of diuretic agents in conscious rats.
    Stier CT, Manning M, Sawyer WH.
    J Pharmacol Exp Ther; 1980 Mar 03; 212(3):412-7. PubMed ID: 7359343
    [Abstract] [Full Text] [Related]

  • 19. Diuretic activity of the aqueous extracts of Carum carvi and Tanacetum vulgare in normal rats.
    Lahlou S, Tahraoui A, Israili Z, Lyoussi B.
    J Ethnopharmacol; 2007 Apr 04; 110(3):458-63. PubMed ID: 17113735
    [Abstract] [Full Text] [Related]

  • 20. U-37883A potently inhibits dopamine-modulated K+ channels on rat striatal neurons.
    Lin YJ, Chen X, Freedman JE.
    Eur J Pharmacol; 1998 Jul 10; 352(2-3):335-41. PubMed ID: 9716371
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.